Sign In
Buy URGN
$26.60
+0.0600 (+0.226%)
At Close: Jun 03, 2026
URGN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against UroGen Pharma Ltd. - July 28, 2025 Deadline
07:30am, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UroGen
Shareholders that lost money on UroGen Pharma Ltd.(URGN) should contact Levi & Korsinsky about pending Class Action - URGN
05:45am, Tuesday, 10'th Jun 2025
NEW YORK , June 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd.
Class Action Alert: Levi & Korsinsky Reminds UroGen Pharma Ltd. (URGN) Investors of July 28, 2025 Deadline
09:45pm, Monday, 09'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
Levi & Korsinsky Urges UroGen Pharma Ltd. (URGN) Shareholders to Act Before Lead Plaintiff Deadline July 28, 2025
04:00pm, Monday, 09'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 28, 2025 in UroGen Pharma Ltd. Lawsuit – URGN
01:36pm, Monday, 09'th Jun 2025
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of UroGen Pharma Ltd. (NASDAQ: URGN).
Join Class Action to Recover Losses from UroGen Pharma Ltd. (URGN) - Contact Levi & Korsinsky Before July 28, 2025
12:15pm, Monday, 09'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
UroGen Pharma Ltd. (URGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
12:00pm, Monday, 09'th Jun 2025
BENSALEM, Pa. , June 9, 2025 /PRNewswire/ -- The Law Offices of Howard G.
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Phar
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. ("UroGen" or the "Company") (NASDAQ:URGN).
Class Action Filed Against UroGen Pharma Ltd. (URGN) Over Securities Violations - Contact Levi & Korsinsky Today
09:30am, Monday, 09'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit with the Schall Law Firm
09:20am, Monday, 09'th Jun 2025
LOS ANGELES , June 9, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UroGen Pharma Ltd. ("UroGen" or "
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd. et al., No. 3:25-cv-06088 (D. N.J.) has been filed and seeks to represent inves
Investors in UroGen Pharma Ltd. (URGN): Protect Your Rights - Contact Levi & Korsinsky Before July 28, 2025
08:50am, Monday, 09'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
